Ying Peng Selected Research

Carcinogenesis

1/2021	The role of P62 in the development of human thyroid cancer and its possible mechanism.
1/2020	Overcoming Taxol-resistance in A549 cells: A comprehensive strategy of targeting P-gp transporter, AKT/ERK pathways, and cytochrome P450 enzyme CYP1B1 by 4-hydroxyemodin.
10/2016	Knockdown of FOXK1 alone or in combination with apoptosis-inducing 5-FU inhibits cell growth in colorectal cancer.
9/2015	Genome-wide analysis of YB-1-RNA interactions reveals a novel role of YB-1 in miRNA processing in glioblastoma multiforme.
9/2015	Suppression of KLF8 induces cell differentiation and sensitizes colorectal cancer to 5-fluorouracil.
4/2015	miR-340 suppresses glioblastoma multiforme.
1/2015	Conditional deletion of Men1 in the pancreatic β-cell leads to glucagon-expressing tumor development.
12/2014	Targeting β-catenin signaling for therapeutic intervention in MEN1-deficient pancreatic neuroendocrine tumours.
3/2009	A functional insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for nasopharyngeal carcinoma.
6/2007	Cell cycle-related kinase: a novel candidate oncogene in human glioblastoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ying Peng Research Topics

Disease

115	Neoplasms (Cancer) 05/2024 - 09/2002
45	Inflammation (Inflammations) 04/2024 - 04/2011
30	Infections 03/2024 - 07/2004
23	Alzheimer Disease (Alzheimer's Disease) 02/2023 - 09/2005
19	Nasopharyngeal Carcinoma 01/2022 - 03/2004
16	Stroke (Strokes) 05/2024 - 01/2011
16	Ischemic Stroke 03/2024 - 06/2004
15	Glioma (Gliomas) 12/2023 - 09/2003
15	Neoplasm Metastasis (Metastasis) 11/2023 - 02/2004
15	Type 2 Diabetes Mellitus (MODY) 09/2023 - 12/2011
13	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2022 - 11/2008
12	Hypoxia (Hypoxemia) 03/2024 - 04/2012
12	Breast Neoplasms (Breast Cancer) 03/2024 - 01/2012
12	Hypertension (High Blood Pressure) 01/2022 - 04/2002
11	Cognitive Dysfunction 04/2024 - 10/2009
11	Brain Ischemia (Cerebral Ischemia) 03/2024 - 03/2008
11	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 01/2014
11	Body Weight (Weight, Body) 09/2023 - 10/2013
11	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 08/2007
11	Carcinogenesis 01/2021 - 12/2004
11	Neuroblastoma 01/2018 - 03/2008
10	Pain (Aches) 09/2023 - 04/2011
9	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 02/2014
9	Tuberculosis (Tuberculoses) 10/2023 - 01/2020
9	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 09/2003
9	Lung Neoplasms (Lung Cancer) 10/2020 - 05/2007
9	Liver Cirrhosis (Hepatic Cirrhosis) 01/2017 - 01/2015
8	Heart Failure 05/2024 - 05/2009
8	Ischemia 03/2024 - 09/2015
8	Epilepsy (Aura) 11/2023 - 09/2011
8	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2023 - 05/2012
8	Fibrosis (Cirrhosis) 10/2022 - 12/2015
7	Mitochondrial Diseases (Mitochondrial Disease) 04/2024 - 01/2014
7	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2023 - 02/2012
7	Liver Diseases (Liver Disease) 01/2017 - 01/2015
6	Reperfusion Injury 03/2024 - 04/2015
6	Wounds and Injuries (Trauma) 03/2024 - 11/2010
6	Colonic Neoplasms (Colon Cancer) 11/2023 - 04/2003
6	Non-alcoholic Fatty Liver Disease 03/2023 - 01/2018
6	Memory Disorders (Memory Loss) 10/2022 - 03/2008
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2022 - 01/2012
6	Hemorrhage 01/2021 - 01/2014
6	Carcinoma (Carcinomatosis) 01/2021 - 02/2004
5	Neuroinflammatory Diseases 03/2024 - 01/2017
5	Dementia (Dementias) 02/2024 - 04/2013
5	Infarction (Infarctions) 10/2023 - 04/2012
5	Brain Injuries (Brain Injury) 10/2023 - 04/2013
5	Insulin Resistance 03/2023 - 03/2018

Drug/Important Bio-Agent (IBA)

47	Proteins (Proteins, Gene)FDA Link 03/2024 - 07/2005
28	Biomarkers (Surrogate Marker)IBA 03/2024 - 05/2009
19	Therapeutic UsesIBA 02/2024 - 10/2006
18	CytokinesIBA 03/2024 - 06/2012
18	MicroRNAs (MicroRNA)IBA 12/2023 - 09/2010
17	Neuroprotective AgentsIBA 02/2024 - 03/2008
16	Peptides (Polypeptides)IBA 03/2024 - 04/2012
16	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 09/2005
15	EnzymesIBA 02/2024 - 01/2004
11	RNA (Ribonucleic Acid)IBA 12/2023 - 02/2014
11	AntioxidantsIBA 10/2023 - 01/2004
11	3-n-butylphthalide (butylphthalide)IBA 02/2018 - 06/2004
10	Messenger RNA (mRNA)IBA 12/2023 - 05/2007
10	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2023 - 01/2004
10	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 04/2012
9	Interleukin-6 (Interleukin 6)IBA 04/2024 - 05/2007
9	PotassiumIBA 02/2024 - 04/2012
9	Small Interfering RNA (siRNA)IBA 01/2024 - 03/2004
8	Ethanol (Ethyl Alcohol)IBA 12/2022 - 11/2010
7	Phosphotransferases (Kinase)IBA 05/2024 - 06/2007
7	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2024 - 01/2012
7	LipidsIBA 05/2024 - 01/2021
7	LipopolysaccharidesIBA 02/2024 - 11/2012
7	Oxygen (Dioxygen)IBA 01/2023 - 04/2012
7	MetalsIBA 03/2022 - 01/2014
7	Amyloid beta-PeptidesIBA 06/2010 - 01/2006
6	2-(1-hydroxypentyl)-benzoateIBA 02/2024 - 04/2012
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2024 - 05/2007
6	Transcription Factors (Transcription Factor)IBA 10/2023 - 01/2015
6	NF-kappa B (NF-kB)IBA 09/2023 - 03/2009
6	Morphine (MS Contin)FDA LinkGeneric 01/2023 - 04/2011
6	Glutathione (Reduced Glutathione)IBA 09/2022 - 12/2018
6	1-phenyl-3,3-dimethyltriazene (PDT)IBA 09/2022 - 11/2019
6	Glutamic Acid (Glutamate)FDA Link 01/2020 - 03/2014
6	ProdrugsIBA 11/2019 - 08/2009
5	InflammasomesIBA 04/2024 - 08/2018
5	CollagenIBA 03/2024 - 01/2015
5	Monoclonal AntibodiesIBA 09/2023 - 10/2011
5	salicylhydroxamic acid (SHAM)IBA 07/2023 - 11/2013
5	Alanine Transaminase (SGPT)IBA 03/2023 - 12/2015
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 09/2012
5	Long Noncoding RNAIBA 01/2023 - 01/2017
5	AcidsIBA 08/2022 - 10/2016
5	Blood Glucose (Blood Sugar)IBA 07/2022 - 01/2020
5	AlbuminsIBA 05/2022 - 04/2012

Therapy/Procedure

57	Therapeutics 01/2024 - 08/2005
14	Immunotherapy 03/2024 - 01/2006
14	Drug Therapy (Chemotherapy) 11/2023 - 09/2003
13	Radiotherapy 01/2022 - 06/2007
11	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2024 - 11/2008
8	Intravenous Injections 09/2022 - 10/2013
7	Photochemotherapy (Photodynamic Therapy) 12/2022 - 11/2019